PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia
| Autor: | Wolff, Nicholas C., Veach, Darren R., Tong, William P., Bornmann, William G., Clarkson, Bayard, Ilaria, Robert L., Jr |
|---|---|
| Zdroj: | In Blood 15 May 2005 105(10):3995-4003 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|